BACKGROUND: Decreased renal cortical neuronal NO synthase (nNOS) abundance/activity correlates with progression of chronic kidney disease (CKD) in a number of animal models. METHODS: Western blotting with both N-terminal and C-terminal antibodies, immunoprecipitation, proteomics, RT-PCR and in situ hybridization were used to identify nNOS splice variants in the rat kidney. RESULTS: We have identified two nNOS proteins and transcripts in the rat kidney; nNOSalpha (approximately 160 kDa) and nNOSbeta (approximately 140 kDa), a catalytically active exon-2 deletion variant, lacking both the PDZ and protein inhibitor of nNOS (PIN) domains. We also report that nNOSbeta protein abundance is increased in the kidney at 11 weeks following 5/6th nephrectomy (5/6NX)-induced CKD while nNOSalpha protein abundance is diminished. The transcript data parallel the protein data in 5/6NX. By in situ hybridization, there is abundant nNOSalpha mRNA widely distributed throughout the normal kidney cortex, with very sparse nNOSbeta mRNA confined to a few proximal tubules. In a second injury model (6 weeks after 5/6 renal mass reduction by combined right kidney ablation and infarction of approximately 2/3 of the left kidney; 5/6 A/I), nNOSalpha mRNA almost disappears from the kidney cortex while nNOSbeta mRNA abundance increases in tubules and tubulo-interstitium. CONCLUSION: The renal cortical nNOSbeta protein is present in low abundance in the normal kidney and increases with injury, in an inverse pattern of change with the nNOSalpha.
BACKGROUND:Decreased renal cortical neuronal NO synthase (nNOS) abundance/activity correlates with progression of chronic kidney disease (CKD) in a number of animal models. METHODS: Western blotting with both N-terminal and C-terminal antibodies, immunoprecipitation, proteomics, RT-PCR and in situ hybridization were used to identify nNOS splice variants in the rat kidney. RESULTS: We have identified two nNOS proteins and transcripts in the rat kidney; nNOSalpha (approximately 160 kDa) and nNOSbeta (approximately 140 kDa), a catalytically active exon-2 deletion variant, lacking both the PDZ and protein inhibitor of nNOS (PIN) domains. We also report that nNOSbeta protein abundance is increased in the kidney at 11 weeks following 5/6th nephrectomy (5/6NX)-induced CKD while nNOSalpha protein abundance is diminished. The transcript data parallel the protein data in 5/6NX. By in situ hybridization, there is abundant nNOSalpha mRNA widely distributed throughout the normal kidney cortex, with very sparse nNOSbeta mRNA confined to a few proximal tubules. In a second injury model (6 weeks after 5/6 renal mass reduction by combined right kidney ablation and infarction of approximately 2/3 of the left kidney; 5/6 A/I), nNOSalpha mRNA almost disappears from the kidney cortex while nNOSbeta mRNA abundance increases in tubules and tubulo-interstitium. CONCLUSION: The renal cortical nNOSbeta protein is present in low abundance in the normal kidney and increases with injury, in an inverse pattern of change with the nNOSalpha.
Authors: John M Arthur; Visith Thongboonkerd; Janice A Scherzer; Jian Cai; William M Pierce; Jon B Klein Journal: Kidney Int Date: 2002-10 Impact factor: 10.612
Authors: Y Wang; D C Newton; G B Robb; C L Kau; T L Miller; A H Cheung; A V Hall; S VanDamme; J N Wilcox; P A Marsden Journal: Proc Natl Acad Sci U S A Date: 1999-10-12 Impact factor: 11.205
Authors: Deyin Lu; Yiling Fu; Arnaldo Lopez-Ruiz; Rui Zhang; Ramiro Juncos; Haifeng Liu; R Davis Manning; Luis A Juncos; Ruisheng Liu Journal: Am J Physiol Renal Physiol Date: 2010-03-24
Authors: Jennifer C Sullivan; Jennifer L Pardieck; Kelly A Hyndman; Jennifer S Pollock Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-11-04 Impact factor: 3.619
Authors: Adam Hosszu; Zsuzsanna Antal; Lilla Lenart; Judit Hodrea; Sandor Koszegi; Dora B Balogh; Nora F Banki; Laszlo Wagner; Adam Denes; Peter Hamar; Peter Degrell; Adam Vannay; Attila J Szabo; Andrea Fekete Journal: J Am Soc Nephrol Date: 2016-04-07 Impact factor: 10.121
Authors: Jennifer M Sasser; Oladele Akinsiku; Natasha C Moningka; Katie Jerzewski; Chris Baylis; Amanda J LeBlanc; Lori S Kang; Amy L Sindler; Judy M Muller-Delp Journal: Gend Med Date: 2012-07-20
Authors: Kelly A Hyndman; Jing Xue; Alexander MacDonell; Joshua S Speed; Chunhua Jin; Jennifer S Pollock Journal: Clin Exp Pharmacol Physiol Date: 2013-03 Impact factor: 2.557